Myocarditis Surveillance with High-Sensitivity Troponin I During Cancer Treatment with Immune Checkpoint Inhibitors.

Waliany, Sarah; Neal, Joel W; Reddy, Sunil; Wakelee, Heather; Shah, Sumit A; Srinivas, Sandy; Padda, Sukhmani K; Fan, Alice C; Colevas, A Dimitrios; Wu, Sean M; Witteles, Ronald M; Zhu, Han

Waliany, Sarah; Neal, Joel W; Reddy, Sunil; Wakelee, Heather; Shah, Sumit A; Srinivas, Sandy; Padda, Sukhmani K; Fan, Alice C; Colevas, A Dimitrios; Wu, Sean M; Witteles, Ronald M; Zhu, Han.

Afiliação

Waliany S; Department of Medicine, Stanford University School of Medicine.
Neal JW; Department of Medicine, Stanford University School of Medicine.
Reddy S; Division of Oncology, Stanford University School of Medicine.
Wakelee H; Stanford Cancer Institute.
Shah SA; Department of Medicine, Stanford University School of Medicine.
Srinivas S; Division of Oncology, Stanford University School of Medicine.
Padda SK; Stanford Cancer Institute.
Fan AC; Department of Medicine, Stanford University School of Medicine.
Colevas AD; Division of Oncology, Stanford University School of Medicine.
Wu SM; Stanford Cancer Institute.
Witteles RM; Department of Medicine, Stanford University School of Medicine.
Zhu H; Division of Oncology, Stanford University School of Medicine.

JACC CardioOncol ; 3(1): 137-139, 2021 Mar.

Article em En | MEDLINE | ID: mdl-33796869

Palavras-chave

Immune checkpoint inhibitors; biomarker; cardiotoxicity surveillance; myocarditis; troponin I

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: JACC CardioOncol Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google